April, 2023
Read More
The connected drug delivery devices market is among the fastest-growing medical device types worldwide. Driven by the potential benefits of smart delivery, patients and healthcare providers across markets are procuring connected drug delivery devices. The report analyzes the market prospects for connected sensors and integrated connected devices. In addition, the devices using Bluetooth technology, Near Field Communication (NFC) technology, and Wi-Fi technologies for drug delivery are assessed and forecasted up to 2030. The end-user segment market revenue across hospitals, clinics, and home care is provided over the forecast period. In addition, the leading market players and their profiles are included.
Connected Drug Delivery Devices Market Study Highlights, 2023
Connected Drug Delivery Devices Market Outlook to 2030
Connected Drug Delivery Devices Market Overview
The Connected Drug Delivery Devices market is rapidly emerging with the growing healthcare expenditures and increasing prevalence of chronic conditions across the world. Further, technological advancements in connected drug delivery services are encouraging wide adoption across hospitals and clinical settings.
Increased preference for use of telehealth services is encouraging market growth for Connected Drug Delivery Devices across developed and developing countries. Most manufacturing companies are focusing on launching cost-efficient Connected Drug Delivery Devices to cater to strong demand growth from emerging markets.
During the COVID-19 pandemic period, the connected drug delivery devices market witnessed an increase in business revenue, due to the lockdown, increased telemedicine spending by patients, and increased adoption across hospital and clinical settings. Further, the market is likely to continue robust growth through 2021 and beyond. Key factors supporting the market growth include potential advantages for stakeholders across the industry, rising prevalence of chronic diseases, increasing geriatric population and growing healthcare expenditures, connected inhaler sensors present strong market potential, and rapid growth of telemedicine supports market growth.
On the other hand, safety, security, and environmental regulations, lack of trained personnel, and limited awareness in developing countries, and others will pose challenges to market growth.
Connected Drug Delivery Devices Market Trend – Potential advantages for stakeholders across the industry
From health insurance payers, clinicians, and pharmaceutical companies to patients, connected drug delivery devices offer significant advantages.
Insurance companies and state healthcare systems
Outcome-based healthcare is rapidly expanding across insurance companies in developed countries. As insurance payers and state healthcare systems emphasize reducing healthcare costs while ensuring efficient health service, the drive towards connected drug delivery systems is increasing. The connected systems support patient treatment at home, resulting in lower healthcare costs. The growth of biological therapies to treat chronic and acute conditions are further supporting the connected drug delivery devices market. Connected drug delivery devices act as a critical tool to ensure that patients adhere to their therapy regimes and provide the data flows to clinicians and care professionals. Accordingly, overall healthcare treatment efficiency at lower costs is achieved.
Clinicians and care professionals
Clinicians and healthcare service providers can deliver treatment to more patients using connected devices. They can also ensure the patient’s timely adherence to the therapy. Further, ongoing research around remote control of dosage based on data flows on the patient's condition will support the long-term outlook. In addition to a wide application in chronic conditions, clinicians tend to use the devices in more complex therapy environments.
Patients
Increase comfort levels, the option to get treated at home, personalization, lower hospital expenditures, and other advantages are encouraging several patients to opt for connected drug delivery devices. Further, as the data is uploaded to clinicians’ databases, treatment is likely to be more effective for patients, in particular, for those suffering from chronic conditions. Connected devices also play an important role in empowerment through self-management of health and disease, health promotion, and disease prevention.
Pharmaceutical companies
Pharmaceutical companies form a major part of treatment and healthcare outcomes. These companies encourage patients to use their therapies in the suggested manner and measure and manage drug efficiency, in particular, for biological therapies. Further, pharmaceutical companies are also rapidly expanding into offering managed services including training, adoption, adherence monitoring, and helplines for drugs. Patient support programs, demonstrating the success of drugs and others are encouraging companies to build digital capabilities.
Connected Drug Delivery Devices Market Opportunities- Connected inhaler sensors present strong market potential
Connected inhalers with built-in sensors are gaining wide popularity among patients with chronic conditions such as chronic obstructive pulmonary disease (COPD) or asthma. Inhalers feature sensors that connect to a smartphone app, which records the usage data and the data can be shared with physicians. The use of the inhaler sensors technology can ensure patients do not overuse their inhalers and also ensures medication is taken on a regular basis.
It is the largest sub-segment in connected sensors type of drug delivery devices, with the other type being connectable Injection Sensors. During 2022, connected inhaler sensors accounted for 38.2% of the total connected drug delivery devices market. Other important types of connected drug delivery devices include Connectable Injection Sensors, Connected Inhalation Devices, and Connected Injection Devices.
Connected Drug Delivery Devices Market Share Analysis- Increase in Demand for sensors
A steep rise in the demand for low-cost sensors in connected drug delivery systems is increasingly observed. Drug delivery devices are incorporated with sensors that allow monitoring of the patient's condition, dosage, and other information. Connected sensors enable the transmission and processing of data captured by mobile sensors using algorithms to support patient supervision and counseling in the home setting.
The connected sensors dominate the global connected drug delivery devices market, accounting for 67% of the total market size during 2022. The connected sensors can be broadly classified into Connected Inhaler Sensors and Connectable Injection Sensors.
As they can be connected to existing devices without interfering with their regular functioning, connected sensors present benefits of low-cost advantages, ease of manufacturing and use by customers, and can be reused after disposing of the drug delivery device. Technological advancements in connectivity, IoT, and other technologies, and growing consumer preference supports the market.
Connected Drug Delivery Devices Market Segmentation
Types
Technologies
Applications
Companies Profiled in the Research Study-
Regions
1. Executive Summary
1.1 Introduction to Connected Drug Delivery Devices Markets
1.2 Connected Drug Delivery Devices Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in the Connected Drug Delivery Devices Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Connected Drug Delivery Devices Market Trends
3.1.1 Potential advantages for stakeholders across the industry
3.1.2 Rising Prevalence of Chronic Diseases
3.1.3 Foray of New players
3.2 Key Connected Drug Delivery Devices Market Growth Drivers
3.2.1 Increasing Geriatric population and growing healthcare expenditures
3.2.2 Connected inhaler sensors present strong market potential
3.2.3 Rapid growth of Telemedicine supports market growth
3.3 Key Connected Drug Delivery Devices Market Growth Restraints
3.3.1 Safety, Security, and Environmental Regulations
3.3.2 Lack of trained personnel
3.3.3 Lack of awareness in developing countries
4 Connected Drug Delivery Devices Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts: Connected Drug Delivery Devices Market Size Outlook to 2030
4.2 Reference Growth Case Scenario Forecasts: Connected Drug Delivery Devices Market Size Outlook to 2030
4.3 High Growth Case Scenario Forecasts: Connected Drug Delivery Devices Market Size Outlook to 2030
5. Connected Drug Delivery Devices Market Segmentation- Outlook by Type
5.1 Connected Drug Delivery Devices Market Share Analysis by Type, 2023
5.2 Connected Sensors Market Outlook to 2030
5.3 Integrated Connected Devices Market Outlook to 2030
6. Connected Drug Delivery Devices Market Segmentation- Outlook by Technology
6.1 Connected Drug Delivery Devices Market Share Analysis by Technology, 2023
6.2 Bluetooth Connected Drug Delivery Devices Market Outlook to 2030
6.3 NFC Connected Drug Delivery Devices Market Outlook to 2030
6.4 Wi-Fi Connected Drug Delivery Devices Market Outlook to 2030
7. Connected Drug Delivery Devices Market Segmentation- Outlook by Application
7.1 Connected Drug Delivery Devices Market Share Analysis by Application, 2023
7.2 Hospital: Connected Drug Delivery Devices Market Outlook to 2030
7.3 Clinics: Connected Drug Delivery Devices Market Outlook to 2030
7.4 Homecare: Connected Drug Delivery Devices Market Outlook to 2030
8. North America Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Connected Drug Delivery Devices Market Growth Opportunities
8.2.1 North America Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
8.2.2 North America Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
8.2.3 North America Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
8.3 United States Connected Drug Delivery Devices Market Outlook, 2021 to 2030
8.4 Canada Connected Drug Delivery Devices Market Outlook, 2021 to 2030
8.5 Mexico Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9. Europe Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Connected Drug Delivery Devices Market Growth Opportunities
9.2.1 Europe Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
9.2.2 Europe Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
9.2.3 Europe Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
9.3 Germany Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.4 France Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.5 United Kingdom Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.6 Spain Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.7 Italy Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.8 Other Europe Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10. Asia Pacific Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Connected Drug Delivery Devices Market Growth Opportunities
10.2.1 Asia Pacific Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
10.2.2 Asia Pacific Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
10.2.3 Asia Pacific Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
10.3 China Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.4 Japan Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.5 India Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.6 South Korea Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.7 Indonesia Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.8 Other Asia Pacific Connected Drug Delivery Devices Market Outlook, 2021 to 2030
11. South and Central America Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 South and Central America Connected Drug Delivery Devices Market Growth Opportunities
11.2.1 South and Central America Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
11.2.2 South and Central America Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
11.2.3 South and Central America Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
11.3 Brazil Connected Drug Delivery Devices Market Outlook, 2021 to 2030
11.4 Argentina Connected Drug Delivery Devices Market Outlook, 2021 to 2030
11.5 Other Latin America Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12. Middle East and Africa Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and Africa Connected Drug Delivery Devices Market Growth Opportunities
12.2.1 Middle East and Africa Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
12.2.2 Middle East and Africa Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
12.2.3 Middle East and Africa Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
12.3 Saudi Arabia Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.4 United Arab Emirates (the UAE) Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.5 Other Middle East Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.6 Egypt Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.7 South Africa Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.8 Other Africa Connected Drug Delivery Devices Market Outlook, 2021 to 2030
13. Profiles of major world Connected Drug Delivery Devices Companies
13.1 Phillips Medisize
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.2 Teva Pharmaceutical Industries Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.3 Propeller Health
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.4 Elcam Medical
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.5 Merck KGaA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.6 West Pharmaceutical Services, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.7 BIOCORP
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.8 Aterica
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
- Financial Profile
13.9 Adherium Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
- Financial Profile
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
Potential advantages for stakeholders across the industry; Rising Prevalence of Chronic Diseases; Increasing Geriatric population and growing healthcare expenditures; connected inhaler sensors present strong market potential; Rapid growth of Telemedicine supports market growth;
The global Connected Drug Delivery Devices Market Size stood at US$ 355 million in 2022
The global Connected Drug Delivery Devices Market Size is poised to register 27.2% growth over the forecast period from 2023 to 2030
Phillips Medisize, Teva Pharmaceutical Industries Ltd, Propeller Health, Elcam Medical, Merck KGaA, West Pharmaceutical Services Inc, BIOCORP, Aterica, Adherium Ltd.
Connected Sensors held the largest share of around two-thirds of market revenue in the global markets